{"slug":"semaglutide-gabapentin","verification":{"valid":true,"entries":2,"head":"5e3cb4f64cf864180c53427f16f27c3a749369e3f161225af3ff3ffdc271eecd"},"energy":{"passes":2,"tokens_in":14061,"tokens_out":2889,"tokens_total":16950,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"5e3cb4f64cf864180c53427f16f27c3a749369e3f161225af3ff3ffdc271eecd"},"provenance":[{"ts":"2026-06-30T00:28:03.062Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semaglutide for Gabapentin\nSlug: semaglutide-gabapentin\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Gabapentin / pregabalin\",\"condition_key\":\"gabapentin-lyrica\",\"primary_peptide\":\"semaglutide\",\"peptides_in_scope\":[{\"id\":\"semaglutide\",\"name\":\"Semaglutide\"}],\"drugs_in_scope\":[\"gabapentin-lyrica\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Gabapentin / pregabalin\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semaglutide\",\"name\":\"Semaglutide\",\"section_title\":\"Why Semaglutide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"You are reading about **Gabapentin / pregabalin** — what breaks down matters before any compound name.\",\"**What keeps failing:** Weight-related joint and disc overload; metabolic stress on repair capacity.\",\"**What Semaglutide is studied to do:** Studied for GLP-1-driven weight loss — reduces mechanical load on weight-sensitive tissues.\",\"**Therefore for you:** If that layer is part of your problem, Semaglutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Gabapentin / pregabalin** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Weight-related joint and disc overload; metabolic stress on repair capacity.\\n3. **What Semaglutide is studied to do:** Studied for GLP-1-driven ","response":"{\"slug\":\"semaglutide-gabapentin\",\"title\":\"Semaglutide and Gabapentin: Metabolic Load, Weight Effects, and Repair-vs-Suppression Framing\",\"body\":\"## What's breaking down if you have Gabapentin / pregabalin\\n\\nGabapentin and pregabalin primarily act by binding to voltage-gated calcium channels. This reduces excitatory neurotransmitter release. The result is dampened nerve signaling. \\n\\nIf you take these drugs, the main layer that can shift is metabolic. Clinical reports show weight gain occurs in a subset of users. One review notes effects in up to 25% of patients. Another analysis of trial data puts the figure near 2%. Mechanisms discussed include increased appetite, fluid retention or edema, and reduced activity from sedation or fatigue. \\n\\nWeight gain adds mechanical stress to joints and the spine. Each extra pound of body weight can transmit roughly four pounds of compressive force through the lumbar discs during activity. Over time this may outpace natural repair capacity in weight-sensitive tissues. \\n\\nThe drug itself does not target tissue repair. It masks the pain signal. Any downstream metabolic change therefore sits outside its direct action.\\n\\n## Why Semaglutide might help you\\n\\n1. You are reading about Gabapentin / pregabalin — what breaks down matters before any compound name.\\n2. What keeps failing: Weight-related joint and disc overload plus metabolic stress on repair capacity can appear when gabapentin use leads to added body weight.\\n3. What Semaglutide is studied to do: GLP-1 receptor agonism drives appetite reduction and weight loss in human trials.\\n4. Therefore for you: If the weight-gain layer is active in your situation, semaglutide is discussed because it targets metabolic load and body weight reduction. It does not act on nerve signaling or replace the pain-masking effect of gabapentin.\\n\\nNo human data directly test semaglutide for gabapentin-induced weight gain or for any repair benefit in this context. The logic follows from separate e","tokens_in":14061,"tokens_out":2889,"cost":0,"prev":"genesis","hash":"b7070ac2d95e33cd32f40b60345b2797f3f2a108d72b2d16b83a92afdbb6a96a"},{"ts":"2026-07-17T02:41:45.150Z","model":"owner","action":"voxel_divide","prompt":"","input":"semaglutide-gabapentin","response":"29 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"b7070ac2d95e33cd32f40b60345b2797f3f2a108d72b2d16b83a92afdbb6a96a","hash":"5e3cb4f64cf864180c53427f16f27c3a749369e3f161225af3ff3ffdc271eecd"}]}